Philipp Raess

Associate Professor

Oregon Health & Science University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Philipp Raess is an Associate Professor at Oregon Health & Science University in the United States. His research primarily focuses on hematologic malignancies, including acute myeloid leukemia and various lymphoid neoplasms, as evidenced by his recent publications. He is actively engaged in exploring the genetic profiling of leukemias and the clinical implications of mutations in his studies.

Articles (13)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Wei Xie

Assistant professor

Oregon Health & Science University

UNITED STATES

View details

Catalina Amador

Associate Professor

University of Miami Health System

UNITED STATES

View details

Emily F. Mason

UNITED STATES

View details

Peng Li

University of Utah Health

UNITED STATES

View details

Richard Press

Oregon Health & Science University

UNITED STATES

View details

Erika Moore

Assistant Professor of Hematopathology; Co-director of Hematology Laboratory

University of Pittsburgh Medical Center

UNITED STATES

View details

Maedeh Mohebnasab

Assistant Professor

UPMC Presbyterian

UNITED STATES

View details

Lynette Smith

Assistant Professor

University of Nebraska Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Philipp Raess

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Clonally related benign cephalic histiocytosis, histiocytic sarcoma, and T‐cell acute lymphoblastic leukemia: Expanding the spectrum of histiocytic transdifferentiation

Distinguishing STAT3/STAT5B-mutated large granular lymphocyte leukemia from myeloid neoplasms by genetic profiling

Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase

Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group

Treatment-Resistant Edematous Annular Plaques and Mild Leukopenia in a Man in His 60s

Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice

Adult acute myeloid leukemia patients with NUP98 rearrangement have frequent cryptic translocations and unfavorable outcome

Cutaneous Plasmacytosis and Idiopathic Multicentric Castleman Disease: A Spectrum of Disease?

NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype

Acute megakaryoblastic leukemia arising in a mediastinal mixed germ cell tumor

Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies

Mast cell sarcoma with concurrent mast cell leukaemia

Erythroblastic sarcoma with rare PDGFRA rearrangement responding to tyrosine kinase inhibitor therapy

Collaborators (8)

Wei Xie

Catalina Amador

Emily F. Mason

Peng Li

Richard Press

Erika Moore

Maedeh Mohebnasab

Lynette Smith

Make your next move.